Padsevonil

DB14977InvestigationalSmall molecule

Padsevonil is under investigation in clinical trial NCT03695094 (A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil).

Formula / weight: C₁₄H₁₄ClF₅N₄O₂S · 432.79 g/mol (avg)

Resolves to

Compound

UNII0R1HN52K0NCAS1294000-61-5

Structure

InChIKeyDCXFIOLWWRXEQH-SSDOTTSWSA-NSMILESCOCC1=NN2C(CN3C[C@@H](CC(F)(F)Cl)CC3=O)=C(N=C2S1)C(F)(F)F

Targets

Q7L0J3SV2A

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

12Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Padsevonil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account